Comprehensive Online Oncology Database
New Medicine Oncology KnowledgeBASE
NEWS
SUBSCRIBER SEARCH
(Requires Login)
NEW DRUG
MARKETED DRUG
COMPANY
TARGETS IN ONCOLOGY
NEWS AND WEBCAST SUMMARIES
COMBINATION TRIALS
  
   1-949-830-0448   info@newmedinc.com   
 
ABOUT nm|OK
nm|OK FREE ACCESS AND DEMO
APPLICATIONS
DESCRIPTION OF MODULES
INQUIRIES AND FEEDBACK
LICENSE AGREEMENT
PRIVACY POLICY
SAMPLE QUERY SCREENS
SAMPLE REPORTS & RECORDS
SOURCES
SUBSCRIPTION INFORMATION
USER GUIDE

PRODUCTS AND SERVICES
FUTURE ONCOLOGY
FEATURED IN-DEPTH REPORTS
CUSTOM REPORT REQUEST

NEWS
NEWS SUMMARIES
LATEST nm|OK UPDATES
nm|OK NEWS RELEASES

SITE MAP
Having trouble finding something?
Use our site map.
 

Latest Updates
June 2006 Marketed Drug Updates and Additions

Brand Name
Generic Name
Numeric Designation
Abraxane Paclitaxel ABI-007
Nolvadex Tamoxifen citrate  
Nexavar Sorafenib tosylate BAY 43-9006
Clolar (USA, formerly Clofarex); Evoltra (Europe) Clofarabine  
Sprycel Dasatinib BMS-354825
Thalidomid, Thalomid, Thalidomide Pharmion (outside the USA) Thalidomide  
Cubicin (formerly Cidecin) Daptomycin  
Eloxatin/Eloxatine, Elplat (Japan) Oxaliplatin (L-OHP) 1670RB, RP 54780
Avastin Bevacizumab rhuMAb-VEGF • NSC-704865
Hycamtin, Hycaptamine Topotecan NSC-609699, SK&F-104864
Ontak (USA), Onzar (Europe) Denileukin diftitox DAB389IL-2
Targretin gel 1% Bexarotene LGD 1069
Avinza (formerly Morphelan) Morphine sulfate  
  Oxaliplatin  
Gardasil    
Velcade Bortezomib MLN341 (formerly LDP-341, PS-341 & MG-341)
Vidaza 5-Azacitidine (AzaC), 5-azacytidine NSC-102816
Nipent Pentostatin or deoxycoformycin  
Cesamet Nabilone  
Multiferon (formerly known as Omniferon) Interferon alpha  


HOME   |   NEW MEDICINE   |   SITE MAP

NEW MEDICINE, INC.
P.O. BOX 909, LAKE FOREST, CA 92609
PHONE:  1-949-830-0448     FAX:  1-949-830-0887
INFO@NEWMEDINC.COM